Proteorex Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Proteorex Therapeutics General Information

Description

Provider of a biotechnology platform created to develop oncology drugs. The company develops oncology drugs using protein-protein interactions (PPIs) between chemical molecule peptides via its proprietary biotechnology platform, enabling physicians and researchers to rapidly and cost-effectively unlock previously undruggable targets.

Contact Information

Website
www.proteorex.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • MaRS West Tower
  • 661 University Avenue, Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • MaRS West Tower
  • 661 University Avenue, Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proteorex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2017 Completed Out of Business
2. Accelerator/Incubator 25-May-2017 Completed Startup
1. Accelerator/Incubator $50K $50K Completed Startup
To view Proteorex Therapeutics’s complete valuation and funding history, request access »

Proteorex Therapeutics Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Proteorex Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016209891-A1 Method of developing small molecule peptide conjugates for biomedical applications Inactive 20-Jan-2015
US-20160245821-A1 Method of developing small molecule peptide conjugates for biomedical applications Inactive 20-Jan-2015

Proteorex Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
SOSV Venture Capital Minority
To view Proteorex Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Proteorex Therapeutics FAQs

  • When was Proteorex Therapeutics founded?

    Proteorex Therapeutics was founded in 2014.

  • Where is Proteorex Therapeutics headquartered?

    Proteorex Therapeutics is headquartered in Toronto, Canada.

  • What industry is Proteorex Therapeutics in?

    Proteorex Therapeutics’s primary industry is Biotechnology.

  • Is Proteorex Therapeutics a private or public company?

    Proteorex Therapeutics is a Private company.

  • What is Proteorex Therapeutics’s current revenue?

    The current revenue for Proteorex Therapeutics is .

  • How much funding has Proteorex Therapeutics raised over time?

    Proteorex Therapeutics has raised $300K.

  • Who are Proteorex Therapeutics’s investors?

    SOSV has invested in Proteorex Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »